SpliceBio
S
Active
Biotechnology company developing next-generation gene therapies.
SpliceBio
Biotechnology company developing next-generation gene therapies.
About
SpliceBio is a biotechnology company focused on developing next-generation gene therapies. Their proprietary Protein Splicing platform is designed to overcome the limitations of traditional gene therapy by enabling the delivery of large genes, which are often implicated in genetic diseases. This technology is based on extensive research in protein engineering and intein biology, originating from Princeton University, and aims to provide new therapeutic options for diseases currently lacking effective treatments.
Tags
Performance
Company Timeline
No timeline data for this period
Score Breakdown
58Traction
40Team
0Visibility
2Profile
0Community
15Discussion (0)
Join the discussion
No comments yet. Be the first to share your thoughts!
Frequently Asked Questions
What does SpliceBio do?
SpliceBio is a biotechnology company focused on developing next-generation gene therapies. Their proprietary Protein Splicing platform is designed to overcome the limitations of traditional gene therapy by enabling the delivery of large genes, which are often implicated in genetic diseases. This technology is based on extensive research in protein engineering and intein biology, originating from Princeton University, and aims to provide new therapeutic options for diseases currently lacking effe…
How much funding has SpliceBio raised?
SpliceBio has raised a total of $135M in funding. The most recent round on record is Series B.
What industry does SpliceBio operate in?
SpliceBio operates in Biotechnology, HealthTech, Gene Therapy.